- $10.27bn
- $11.01bn
- $3.75bn
- 85
- 21
- 94
- 74
2019 September 29th | 2020 September 27th | 2021 October 3rd | 2022 October 2nd | 2023 October 1st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,390 | 2,349 | 2,552 | 2,836 | 3,751 |
Cost of Revenue | |||||
Gross Profit | 408 | 447 | 498 | 576 | 725 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,201 | 2,107 | 2,273 | 2,495 | 3,393 |
Operating Profit | 189 | 241 | 279 | 340 | 358 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 175 | 228 | 267 | 349 | 401 |
Provision for Income Taxes | |||||
Net Income After Taxes | 156 | 174 | 233 | 263 | 273 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 159 | 174 | 233 | 263 | 273 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 159 | 174 | 233 | 263 | 273 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.08 | 3.37 | 4.26 | 4.86 | 5.73 |
Dividends per Share |